Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Comment by Craigbadon Sep 11, 2015 9:37pm
82 Views
Post# 24098136

RE:RE:RE:RE:RE:RE:Peter hodson

RE:RE:RE:RE:RE:RE:Peter hodsonI think you have it backwards Peter, baystreet almost always makes money, its what they do. They invest without emotion and have little patience for small caps who make mistakes or miss quarters as they make up meaningless weightings in their portfolios and they will indiscriminately dump them if they might make them look bad when going over performance with their clients. There are many recent examples like acq, bad, phm, cph, etc. and many never recover. Funds can be a liability to the share price for a company with a high valuation like msl because the minute they see a better opportunity they will dump and move on. You will only fund out they are gone when they are already out and the next time on Bnn they start touting their new purchase and telling you to sell this to buy it.
<< Previous
Bullboard Posts
Next >>